Ferroptosis and renal fibrosis: mechanistic insights and emerging therapeutic targets
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Ferroptosis, a cell death pathway, drives kidney fibrosis by disrupting iron metabolism and causing lipid peroxidation. Targeting ferroptosis offers a promising therapeutic strategy for chronic kidney disease.
Area Of Science
- Biochemistry
- Cell Biology
- Nephrology
Background
- Ferroptosis is an iron-dependent cell death characterized by lipid peroxidation, distinct from other regulated cell death forms.
- Emerging evidence links ferroptosis to the pathogenesis of renal fibrosis, a key feature of chronic kidney disease (CKD).
- Renal fibrosis contributes to high morbidity and progression to end-stage renal failure.
Purpose Of The Study
- To review and synthesize current evidence connecting ferroptotic signaling to kidney fibrotic remodeling.
- To explore ferroptosis as a potential therapeutic target for fibrotic kidney disease.
Main Methods
- Literature review of preclinical studies on ferroptosis and renal fibrosis.
- Focus on mechanisms including iron metabolism, GPX4 inactivation, lipid peroxidation, and regulatory pathways (FSP1-CoQ10-NAD(P)H, GCH1-BH4).
- Analysis of ferroptosis's role in tubular epithelial cells and its impact on pro-fibrotic signaling and ECM deposition.
Main Results
- Dysregulation of iron metabolism and inactivation of GPX4 promote ferroptosis in kidney disease.
- Accumulation of lipid peroxides and activation of specific ferroptosis pathways contribute to fibrotic processes.
- Ferroptosis in tubular cells influences cytokine release, macrophage infiltration, and TGF-β1-mediated extracellular matrix deposition.
Conclusions
- Ferroptosis is a significant driver of renal fibrosis, representing a therapeutic vulnerability in CKD.
- Therapeutic strategies targeting ferroptosis, including iron chelators and GPX4 activators, show promise.
- Further research into ferroptosis modulation could lead to novel treatments for fibrotic kidney diseases.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
